The Leo Innovation Lab in Markham will develop new, non-pharmaceutical solutions for people living with psoriasis and partner with the startup community to foster innovation in apps, web platforms, wearables, virtual reality, artificial intelligence, telemedicine and other advanced technologies.
Through its newly announced Leo Ventures initiative, the innovation lab is also prepared to invest in and give grants to startups to help contribute to finding and developing solutions. The Leo Innovation Lab itself has been established with non-profit requirements and is part of a long-term strategic decision by LEO Pharma to put people at the centre, even if there is no immediate financial gain from doing so, explains Gitte Aabo, CEO of Leo Pharma and a member of Leo Innovation Lab’s board.
According to a recent survey, psoriasis affects approximately affect 125 million people around the world.
“We know that psoriasis affects many aspects of daily life beyond ones that can be treated with medication,” said Miron Derchansky, head of Leo’s Innovation Lab in Toronto. “Leo Pharma has been developing pharmaceutical products since 1908, and now we’re turning to the digital space and the startup community to help us hack new and creative solutions to help people better manage and deal with their condition.”
The lab will focus on areas such as stress, diet, social relationships and healthcare provider interaction. Leo Canada’s CEO, Xavier Bertin, in partnership with Miron Derchansky, will ensure the ideas generated in the Innovation Lab are tested in the Canadian marketplace.
SAMSUNG GALAXY S8 PLUS
The Samsung Galaxy S8 Plus is a beautifully crafted smartphone with nearly no bezel, curvaceous in design and reflects a…
How to: Connect to Exchange Online Using Multi-Factor Authentication
Using PowerShell to manage your Microsoft cloud services like Exchange Online and using multi-factor authentication (MFA) separately is awesome. Using…